IRIS
LUCARELLI, GIUSEPPE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.743
EU - Europa 1.318
NA - Nord America 1.241
SA - Sud America 240
AF - Africa 53
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 4.597
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.181
SG - Singapore 897
RU - Federazione Russa 715
CN - Cina 389
BR - Brasile 190
VN - Vietnam 179
IT - Italia 164
HK - Hong Kong 126
DE - Germania 123
GB - Regno Unito 81
NL - Olanda 69
FR - Francia 48
IN - India 47
FI - Finlandia 43
AR - Argentina 26
KR - Corea 25
CA - Canada 23
MX - Messico 23
ZA - Sudafrica 19
CI - Costa d'Avorio 18
BD - Bangladesh 14
PL - Polonia 13
AT - Austria 10
TR - Turchia 9
ID - Indonesia 8
IQ - Iraq 8
UA - Ucraina 8
JP - Giappone 7
CZ - Repubblica Ceca 6
LT - Lituania 6
SE - Svezia 6
EC - Ecuador 5
IR - Iran 5
PK - Pakistan 5
UZ - Uzbekistan 5
CL - Cile 4
DK - Danimarca 4
ES - Italia 4
IE - Irlanda 4
PY - Paraguay 4
VE - Venezuela 4
JM - Giamaica 3
NP - Nepal 3
PA - Panama 3
PE - Perù 3
PH - Filippine 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BG - Bulgaria 2
CH - Svizzera 2
CO - Colombia 2
DO - Repubblica Dominicana 2
IL - Israele 2
JO - Giordania 2
KE - Kenya 2
KG - Kirghizistan 2
MA - Marocco 2
NI - Nicaragua 2
PT - Portogallo 2
AL - Albania 1
AM - Armenia 1
AU - Australia 1
BE - Belgio 1
BO - Bolivia 1
BZ - Belize 1
CD - Congo 1
DZ - Algeria 1
EG - Egitto 1
ET - Etiopia 1
GE - Georgia 1
GM - Gambi 1
GR - Grecia 1
GT - Guatemala 1
HR - Croazia 1
IM - Isola di Man 1
MD - Moldavia 1
MG - Madagascar 1
MK - Macedonia 1
ML - Mali 1
MW - Malawi 1
NE - Niger 1
PR - Porto Rico 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UG - Uganda 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
YT - Mayotte 1
Totale 4.597
Salva come PNG Salva come JPEG
Città #
Singapore 436
Moscow 162
Ashburn 157
Hefei 137
Chandler 126
Hong Kong 126
Beijing 111
Santa Clara 71
Naples 64
Amsterdam 61
Munich 58
Dong Ket 56
Los Angeles 47
Enfield 41
Ho Chi Minh City 38
Hanoi 34
Millbury 31
New York 28
Turku 26
Frankfurt am Main 25
Kochi 25
Redondo Beach 25
Lawrence 24
Seoul 24
Dallas 23
Des Moines 22
Boston 21
São Paulo 18
Phoenix 17
Buffalo 15
Chicago 11
Johannesburg 11
Mexico City 11
Orem 11
Ottawa 11
Seattle 11
Warsaw 11
Helsinki 10
Milan 10
The Dalles 10
Bari 9
Napoli 9
Nuremberg 9
Brooklyn 8
Wilmington 8
Chennai 7
Denver 7
Houston 7
Lappeenranta 7
London 7
Tokyo 7
Da Nang 6
Düsseldorf 6
Fairfield 6
Nanjing 6
Vienna 6
Ankara 5
Biên Hòa 5
Council Bluffs 5
Kronberg 5
Lauterbourg 5
Montreal 5
Ninh Bình 5
Poplar 5
Princeton 5
Baghdad 4
Belo Horizonte 4
Bexley 4
Boardman 4
Concepción 4
Dublin 4
Guangzhou 4
Haiphong 4
Pune 4
San Jose 4
Shanghai 4
Siziano 4
Stockholm 4
Tashkent 4
Woodbridge 4
Atlanta 3
Augusta 3
Bengaluru 3
Brasília 3
Cambridge 3
Campinas 3
Changsha 3
Dearborn 3
Dhaka 3
Fortaleza 3
Guarulhos 3
Hebei 3
Manaus 3
Manchester 3
Marijampolė 3
Padova 3
Paris 3
Portsmouth 3
Querétaro 3
Redwood City 3
Totale 2.436
Salva come PNG Salva come JPEG
Nome #
Renal Cell Carcinoma as a Metabolic Disease: An Update on Main Pathways, Potential Biomarkers, and Therapeutic Targets 194
Incidence of fatigue and low-dose corticosteroid use in prostate cancer patients receiving systemic treatment: a meta-analysis of randomized controlled trials 137
Absolute basophil count is associated with time to recurrence in patients with high-grade T1 bladder cancer receiving bacillus Calmette–Guérin after transurethral resection of the bladder tumor 136
Systemic combining inflammatory score (SCIS): a new score for prediction of oncologic outcomes in patients with high-risk non-muscle-invasive urothelial bladder cancer 126
Epigenetic signature: A new player as predictor of clinically significant prostate cancer (PCa) in patients on active surveillance (AS) 124
An increased body mass index is associated with a worse prognosis in patients administered BCG immunotherapy for T1 bladder cancer 122
Metabolomic profiling for the identification of novel diagnostic markers and therapeutic targets in prostate cancer: an update 122
Urinary long noncoding RNAs in nonmuscle-invasive bladder cancer: new architects in cancer prognostic biomarkers 119
Predictors of efficacy of androgen-receptor-axis-targeted therapies in patients with metastatic castration-sensitive prostate cancer: A systematic review and meta-analysis 118
Beyond PSA: The Role of Prostate Health Index (phi) 117
Three vs. Four Cycles of Neoadjuvant Chemotherapy for Localized Muscle Invasive Bladder Cancer Undergoing Radical Cystectomy: A Retrospective Multi-Institutional Analysis 115
Association of statin use and oncological outcomes in patients with first diagnosis of T1 high grade non-muscle invasive urothelial bladder cancer: results from a multicentre study 114
A risk-group classification model in patients with bladder cancer under neoadjuvant cisplatin-based combination chemotherapy 114
The Impact of Meat Intake on Bladder Cancer Incidence: Is It Really a Relevant Risk? 112
Validation of Neutrophil-to-lymphocyte Ratio in a Multi-institutional Cohort of Patients With T1G3 Non–muscle-invasive Bladder Cancer 109
Artificial Intelligence and Machine Learning in Prostate Cancer Patient Management-Current Trends and Future Perspectives 109
Accuracy of the European Association of Urology (EAU) NMIBC 2021 scoring model in predicting progression in a large cohort of HG T1 NMIBC patients treated with BCG 108
Integration of lipidomics and transcriptomics reveals reprogramming of the lipid metabolism and composition in clear cell renal cell carcinoma 108
Impact of Age on Outcomes of Patients With Pure Carcinoma In Situ of the Bladder: Multi-Institutional Cohort Analysis 107
Predictors of residual T1 high grade on re-transurethral resection in a large multi-institutional cohort of patients with primary T1 high-grade/grade 3 bladder cancer 106
The Efficacy of Flogofilm® in the Treatment of Chronic Bacterial Prostatitis as an Adjuvant to Antibiotic Therapy: A Randomized Prospective Trial 105
Prostate cancer radiogenomics—from imaging to molecular characterization 103
Activation of the kynurenine pathway predicts poor outcome in patients with clear cell renal cell carcinoma 100
Liquid biopsy biomarkers in urine: A route towards molecular diagnosis and personalized medicine of bladder cancer 100
The evolving landscape of renal surgery for complex renal masses (CRM): implications for oncologic and functional outcomes 99
Type 2 diabetes mellitus predicts worse outcomes in patients with high-grade T1 bladder cancer receiving bacillus Calmette-Guérin after transurethral resection of the bladder tumor 99
First-line systemic therapy for metastatic castration-sensitive prostate cancer: An updated systematic review with novel findings 98
Circulating preoperative testosterone level predicts unfavourable disease at radical prostatectomy in men with International Society of Urological Pathology Grade Group 1 prostate cancer diagnosed with systematic biopsies 96
Modified Glasgow Prognostic Score as a Predictor of Recurrence in Patients with High Grade Non-Muscle Invasive Bladder Cancer Undergoing Intravesical Bacillus Calmette–Guerin Immunotherapy 96
Predictive clinico-pathological factors to identify BCG, unresponsive patients, after re-resection for T1 high grade non-muscle invasive bladder cancer 95
Radiomics in prostate cancer: an up-to-date review 94
Immune Checkpoint Inhibitors as a Neoadjuvant/Adjuvant Treatment of Muscle-Invasive Bladder Cancer: A Systematic Review 94
Systemic Inflammatory Markers and Oncologic Outcomes in Patients with High-risk Non–muscle-invasive Urothelial Bladder Cancer 94
Novel Key Ingredients in Urinary Tract Health-The Role of D-mannose, Chondroitin Sulphate, Hyaluronic Acid, and N-acetylcysteine in Urinary Tract Infections (Uroial PLUS®) 93
Increased Body Mass Index Is a Risk Factor for Poor Clinical Outcomes after Radical Prostatectomy in Men with International Society of Urological Pathology Grade Group 1 Prostate Cancer Diagnosed with Systematic Biopsies 91
SelectMDx and Multiparametric Magnetic Resonance Imaging of the Prostate for Men Undergoing Primary Prostate Biopsy: A Prospective Assessment in a Multi-Institutional Study 88
Neutrophil percentage-to-albumin ratio predicts mortality in bladder cancer patients treated with neoadjuvant chemotherapy followed by radical cystectomy 85
Surgical blood loss during holmium laser enucleation of the prostate (HoLEP) is not affected by short-term pretreatment with dutasteride: a double-blind placebo-controlled trial on prostate vascularity 84
Immune Checkpoint Inhibitors in Renal Cell Carcinoma: Molecular Basis and Rationale for Their Use in Clinical Practice 84
Quality of Web-Based Patient Information on Robotic Radical Cystectomy Remains Poor: A Standardized Assessment 80
Molecular Imaging Diagnosis of Renal Cancer Using 99mTc-Sestamibi SPECT/CT and Girentuximab PET-CT-Current Evidence and Future Development of Novel Techniques 63
Radiogenomics in Renal Cancer Management-Current Evidence and Future Prospects 62
Percutaneous Ablation vs Robot-Assisted Partial Nephrectomy for Completely Endophytic Renal Masses: A Multicenter Trifecta Analysis with a Minimum 3-Year Follow-Up 60
Emerging Hallmarks of Metabolic Reprogramming in Prostate Cancer 55
Current Management of Urachal Carcinoma: An Evidence-based Guide for Clinical Practice 54
Radiotherapy to the Primary Tumor: The First Step of a Tailored Therapy in Metastatic Prostate Cancer 47
Microwave versus cryoablation and radiofrequency ablation for small renal mass: a multicenter comparative analysis 37
Totale 4.673
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.843
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.843
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021107 0 0 0 0 0 13 2 1 18 7 4 62
2021/2022189 7 3 4 0 2 2 1 3 6 22 70 69
2022/2023436 29 11 16 7 50 38 1 41 60 128 53 2
2023/2024290 6 55 60 22 16 15 5 38 5 2 51 15
2024/20251.649 64 80 0 11 53 61 160 88 133 221 654 124
2025/20261.920 339 288 354 311 495 133 0 0 0 0 0 0
Totale 4.673